Search results
Results From The WOW.Com Content Network
Dual-energy X-ray absorptiometry (DXA, or DEXA [1]) is a means of measuring bone mineral density (BMD) with spectral imaging. Two X-ray beams, with different energy levels, are aimed at the patient's bones. When soft tissue absorption is subtracted, the bone mineral density (BMD) can be determined from the absorption of each beam by bone. Dual ...
A scanner used to measure bone density using dual energy X-ray absorptiometry. Bone density, or bone mineral density, is the amount of bone mineral in bone tissue.The concept is of mass of mineral per volume of bone (relating to density in the physics sense), although clinically it is measured by proxy according to optical density per square centimetre of bone surface upon imaging. [1]
The trabecular bone score is a textural parameter that can be applied to DEXA, which quantifies the local variations in gray level. TBS is derived from the evaluation of the experimental variogram, obtained from the grayscale DEXA. [citation needed] It was found that TBS is a reflection of the structural condition of the bone microarchitecture.
bone density studies for osteoporosis assessment Dual X-ray absorptiometry and laser technique (DXL) in the area of bone density studies for osteoporosis assessment is an improvement to the DXA Technique , adding an exact laser measurement of the thickness of the region scanned.
The United States Preventive Services Task Force recommends osteoporosis screening for women with increased risk over 65 and states there is insufficient evidence to support screening men. [21] The main purpose of screening is to prevent fractures. Of note, USPSTF screening guidelines are for osteoporosis, not specifically osteopenia.
Primary, or involuntary osteoporosis, can further be classified into Type I or Type II. [1] Type I refers to postmenopausal osteoporosis and is caused by the deficiency of estrogen. [1] While senile osteoporosis is categorized as an involuntary, Type II, and primary osteoporosis, which affects both men and women over the age of 70 years.
About 22 million women and 5.5 million men in the European Union had osteoporosis in 2010. [15] In the United States in 2010, about 8 million women and between 1 and 2 million men had osteoporosis. [13] [16] White and Asian people are at greater risk. [3] The word "osteoporosis" is from the Greek terms for "porous bones". [17]
The Royal Osteoporosis Society supports ground-breaking and pioneering research aimed at improving the prevention, diagnosis treatment of osteoporosis. The charity has invested over £5 million in more than 130 projects which have enhanced knowledge and understanding of osteoporosis, leading to significant improvements in diagnosis and treatment.